BenevolentAI Investor Conference Presentation Deck
Business right sized and focussed on value creation
Cash and Cost Base
Cash¹ at 30 June 2023
H1 2023 cash burn of £37.9m before
working capital movements
£84.3m
Cash burn reduced by around 40%²
Cash runway guidance, to at least
Mid-2025, inclusive of Merck, but before
any future unsigned revenue
Headcount reduced by c. 30%, with around
260 employees by year end
Benevolent
1. Includes cash, cash equivalents and short-term deposits (maturity between 3 and 12 months)
2. vs. pre-restructure forecasts for 2024 and 2025.
2
Capital Allocation
BenevolentAl Proprietary
BEN-8744 - Funding Phase I trial in UC
BEN-28010 - Funding IND enabling work in GBM
3 BEN-34712 - Funding IND-enabling work for ALS
Continuous enhancement of the Benevolent Platform™
Investment in Knowledge Exploration tools
Benevolent 10View entire presentation